• 제목/요약/키워드: MMVD

검색결과 13건 처리시간 0.016초

Assessment of Vertebral Left Atrial Size and C-reactive Protein in Dogs With Myxomatous Mitral Valve Disease

  • Hwang, Sun-Hwee;Song, Kun Ho
    • 한국임상수의학회지
    • /
    • 제38권1호
    • /
    • pp.16-20
    • /
    • 2021
  • Recently, a new method of evaluating left atrial size called vertebral left atrial size (VLAS) was introduced in dogs. Total 155 dogs were examined at the Veterinary Medical Teaching Hospital of Chungnam National University. In this study, myxomatous mitral valve disease (MMVD) stage and VLAS showed a significant correlation in those dogs. Also, the relationship between C-reactive protein (CRP) and VLAS has yet to be examined. We found a strong positive correlation between VLAS and CRP-a significant increase in CRP was observed with increasing VLAS values. Thus, it would be beneficial to measure VLAS besides employing the current radiological and echocardiographic methods when evaluating heart size. Measuring VLAS could be an additional diagnostic tool for diagnosing MMVD in dogs.

ECM 의 효율적인 GPM 확장 모드 시그널링 기법 (Efficient Signaling of Extended GPM Modes in ECM)

  • 문기화;이지원;박도현;김재곤
    • 한국방송∙미디어공학회:학술대회논문집
    • /
    • 한국방송∙미디어공학회 2022년도 하계학술대회
    • /
    • pp.1236-1238
    • /
    • 2022
  • JVET 은 최신 비디오 부호화 표준인 VVC(Versatile Video Coding) 표준화를 완료한 후, VVC 보다 더 높은 압축 성능을 가지는 새로운 표준기술 탐색을 진행하고 있으며, 이를 위하여 참조 소프트웨어 ECM(Enhanced Compression Model)을 개발하고 있다. 현재 ECM4.0 에는 다양한 후보 구성 및 예측 성능 개선 기법을 추가하여 기존 VVC 의 GPM(Geometric Partitioning Mode)을 확장한 GPM-MMVD(GPM with merge MV differences), GPM-TM(GPM with template matching) 등을 채택하고 있다. 본 논문에서는 ECM 에 채택된 확장된 GPM 기술들의 각 기술 별 선택 빈도를 분석하고 이를 바탕으로 보다 효율적인 GPM 확장 모드 시그널링 방식을 제안한다. 또한 후보 탐색 알고리즘을 간소화한 복잡도 감소 기법을 제시한다. 실험결과 제안하는 시그널링 기법은 ECM4.0 대비 Y와 Cb, Cr 에서 각각 0.02%, 0.16%, 0.09% BD-rate 부호화 성능 향상을 보였고 GPM 인덱스 탐색 간소화 기법은 ECM4.0 대비 Y 와 Cr 에서 각각 0.02%, 0.18% BD-rate 부호화 성능 향상을 보였다.

  • PDF

Cystatin C for managing diuretic-induced kidney dysfunction in MMVD dogs

  • Donghyun Han;Jae Hyeon Cho;Chung Hui Kim
    • 한국동물위생학회지
    • /
    • 제46권3호
    • /
    • pp.181-192
    • /
    • 2023
  • Cystatin C, a low-molecular-weight protein synthesized by cells, is being explored as a valuable biomarker for assessing renal function in veterinary medicine. Although the relationship between cystatin C and heart disease remains unclear, some studies suggest a possible association. This retrospective case-control study aimed to investigate the role of cystatin C as a biomarker for heart disease and its correlation with diuretic use in veterinary clinical practice. A total of 39 dogs were included in this study, comprising 9 control dogs without a predisposition to heart disease and 30 dogs in the study group diagnosed with heart disease. Among the 30 dogs with heart disease, 18 exhibited symptoms indicative of heart failure. Results showed significantly higher cystatin C levels in the heart disease group compared to the control group (P<0.05). However, no significant differences were observed among different stages of heart disease severity in the control group. Furthermore, cystatin-C showed statistically positive correlations with BUN (r=0.478, P<0.01), creatinine (r=0.506, P<0.01), and furosemide (r=0.338, P<0.05). Diuretics are essential for managing congestive heart failure, and the observed associations between cystatin C and furosemide suggest potential impacts of diuretic use on renal function in dogs with heart failure. Monitoring renal function markers, such as cystatin C, can aid in predicting and managing potential renal complications, ultimately improving the overall health and quality of life of dogs with heart disease.